Literature DB >> 2903385

Endothelin: an important factor in acute renal failure?

J D Firth1, P J Ratcliffe, A E Raine, J G Ledingham.   

Abstract

Very low concentrations of the vasoconstrictor peptide endothelin cause intense long-lasting renal vasoconstriction. In the isolated perfused rat kidney, the concentration of endothelin required to reduce blood-flow by 50% is 200 pmol/l, compared with 1000 pmol/l angiotensin II (previously the most potent known vasoconstrictor). Whereas angiotensin II has little effect on the glomerular filtration rate (GFR), a rise in endothelin from 100 to 800 pmol/l reduces GFR by 90%. Endothelin is probably present in the circulation at low concentrations in vivo; events associated clinically with acute renal failure would tend to increase this concentration. Endothelin may be a mediator in the pathogenesis of acute renal failure.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2903385     DOI: 10.1016/s0140-6736(88)90243-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  26 in total

1.  Endothelin-like pulmonary vasoconstrictor peptide release by alpha-thrombin.

Authors:  D G Moon; M J Horgan; T T Andersen; S R Krystek; J W Fenton; A B Malik
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

Review 2.  Endothelium-dependent vascular responses. Mediators and mechanisms.

Authors:  B M Brenner; J L Troy; B J Ballermann
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

3.  Verotoxigenic (enterohaemorrhagic) Escherichia coli in infants and toddlers in Czechoslovakia.

Authors:  M Bielaszewská; L Srámková; J Janda; K Bláhová; H Ambrozová
Journal:  Infection       Date:  1990 Nov-Dec       Impact factor: 3.553

4.  Elevated plasma endothelin-1 concentrations are associated with the severity of illness in patients with sepsis.

Authors:  J F Pittet; D R Morel; A Hemsen; K Gunning; J S Lacroix; P M Suter; J M Lundberg
Journal:  Ann Surg       Date:  1991-03       Impact factor: 12.969

5.  Effects of moderate hypoxia, hypercapnia and acidosis on haemodynamic changes induced by endothelin-1 in the pithed rat.

Authors:  M R MacLean; M D Randall; C R Hiley
Journal:  Br J Pharmacol       Date:  1989-11       Impact factor: 8.739

6.  Endothelin-1 in the rabbit: interactions with cyclo-oxygenase and NO-synthase products.

Authors:  M E Rogerson; H S Cairns; L D Fairbanks; J Westwick; G H Neild
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

7.  Haemodynamic and renal tubular effects of low doses of endothelin in anaesthetized rats.

Authors:  P J Harris; J Zhuo; F A Mendelsohn; S L Skinner
Journal:  J Physiol       Date:  1991-02       Impact factor: 5.182

8.  Pharmacological intervention for renal protection during cardiopulmonary bypass.

Authors:  K Hashimoto; K Nomura; M Nakano; T Sasaki; H Kurosawa
Journal:  Heart Vessels       Date:  1993       Impact factor: 2.037

9.  Messenger RNA expression and synthesis of endothelin-1 along rat nephron segments.

Authors:  K Ujiie; Y Terada; H Nonoguchi; M Shinohara; K Tomita; F Marumo
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

10.  Organ distribution of the three rat endothelin messenger RNAs and the effects of ischemia on renal gene expression.

Authors:  J D Firth; P J Ratcliffe
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.